ESE Advocacy Representation (EARS) Scheme
The new ESE Advocacy Representation Scheme (EARS), Community, which was launched in October 2020, is open to ESE members and members of the national affiliated societies represented by the ESE Council of Affiliated Societies (ECAS). Join the EARS Community and receive up-to-date information on our policy and advocacy work.
In November 2019, following extensive consultation with all of the ECAS representatives it was agreed to set up the ESE Advocacy Representation Scheme (EARS) with all our Affiliated Societies. At the last ESE Council of Affiliated Societies meeting (May 2020) this was discussed again and formally ratified. It was then presented to the ESE Membership at the AGM held on the 26 May 2020.
You entrusted the European Society of Endocrinology with the task to represent the VOICE for ENDOCRINOLOGY in Brussels. There are many reasons for the National Affiliated Societies and their members to be engaged and support the policy and advocacy environment and activities, but the major one is that WE ARE STRONGER TOGETHER.
Becoming part of the EARS Community is at no cost to the members of the national affiliated societies represented by the ESE Council of Affiliated Societies (ECAS), as the small annual fee of €2.50 will be paid on their behalf by their National Society. Please note that this is separate to any existing ESE membership. This contribution will help support ESE’s Policy and Advocacy work on behalf of all our members.
ESE represents the VOICE for ENDOCRINOLOGY in Brussels. The EARS scheme is set to do that: by creating a European Advocacy Representative Scheme collectively representing a community of more than 22 500 endocrine health care professionals and researchers across Europe. ESE now fully, and in an authoritative way, represents the needs of the endocrine community and the patients they care for.
- Receive regular e-newsletter updates on the Policy and Advocacy work of the Society.
- Have the opportunity to be involved with consultation on, and engagement with, ESE Policy and Advocacy activities.
- Have your voice heard as part of Europe’s community of endocrinology professionals.
- Have access to additional resources, such as the ESE’s White Paper “Hormones in European Health Policies: Contributing towards a healthier Europe” which is due to be published in November 2020.
- Receive invitations to sessions at ECE and other events around Policy and Advocacy and topics such as research funding.
To join the EARS community, which is FREE to both ESE members and members of the national affiliated societies represented by ECAS, as the small fee of €2.50 will be paid on your behalf by your National Society, fill in the below application form.
ESE’s Mission Statement -‘Shaping the Future of Endocrinology’ - means that we actively engage with different stakeholders in creating a European and broader international environment that recognises the important place of ‘endocrine’ health in the development of future health care policies and support to research programmes.
The Policy and Advocacy activities of ESE focus on three areas that are of strategic importance to the European and global health care agenda:
- Achieving greater health care effectiveness and resilience through health promotion and disease prevention, with a specific focus on the post-COVID-19 recovery and impact on and from endocrine and metabolic diseases. This applies to both prevalent and rare diseases.
- Supporting the Cancer Mission, provide input to the ‘Beating Cancer Plan’ and stimulate research with a focus on the endocrine origins and consequences
- Engage in EU debates around climate change and the environment with a focus on endocrine disruptors
The Mission of ESE is about ‘Shaping the Future of Endocrinology’ – a statement that includes many different aspects, from impacting on the many debates around public health and the important roles of hormones in European Health policies, towards supporting the endocrine discipline.
ESE engages with the European Commission and Parliament around many debates that shape European Health Care policies. Over the last 12 months, these engagements have been and are about inserting the hormone health perspective to the Horizon Europe research programme, the Beating Cancer Plan, the support to rare diseases as part of the European Reference Networks, and more recently, driven by the COVID 19 pandemic and its impact on European health care, the EU4 Health programme. The Commission’s Green Deal and as part of that the Chemical Strategy for Sustainability needs to include a strong emphasis on Endocrine Disruptors, a major contributor to the susceptibility to many non-communicable diseases.
With patients with endocrine diseases being more susceptible to the impact of COVID-19 and COVID-19 infections themselves creating longer-term endocrine and metabolic consequences, ESE aims for even more engagement and impact on European policymakers, to address research and clinical care challenges.
With the upcoming publication of the White Paper ‘Hormones in European Health Policies: Contributing towards a Healthier Europe’, ESE will provide a hormone-related policy framework across the areas of prevalent as well as rare diseases, the European Cancer Mission and the efforts to reduce the burden of endocrine-disrupting chemicals.
With the upcoming publication of the White Paper ‘Hormones in European Health Policies: Contributing towards a Healthier Europe’, ESE will provide a hormone related policy framework across the areas of prevalent as well as rare diseases, the European Cancer Mission and the efforts to reduce the burden of endocrine disrupting chemicals.
ESE also works with the Biomedical Alliance in several areas. One is related to mitigating the impact of Plan S – the initiative around open access to publications related to publicly funded research – where we need to draw the attention to the impact this may have on publication options for young researchers, and those from lower income countries. ESE is equally supportive to the call to move forward with a European Health Technology Assessment (HTA) structure, to address the persisting health inequalities across Europe. ESE is also engaged with the Education Committee of the alliance, supporting the role of societies in ongoing medical education for their members.
 The Biomed Alliance (Biomedical Alliance in Europe) is an NGO representing 33 leading European research and medical societies uniting more than 400 000 researchers and healthcare professionals.
To read more about our Policy and Advocacy work visit www.ese-hormones.org/advocacy.
We would like to thank all of the ECAS Societies for their support and involvement in this important Scheme.
To join the EARS community, which is FREE to both ESE members and members of ESE’s National Affiliated Societies, fill in the application form.